These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37321378)

  • 1. CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.
    Huang Q; Wu J; Le N; Shen Y; Guo P; Schreck KC; Kamson D; Blair L; Heo HY; Li X; Li W; Sair HL; Blakeley JO; Laterra J; Holdhoff M; Grossman SA; Mukherjee D; Bettegowda C; van Zijl P; Zhou J; Jiang S
    Magn Reson Imaging; 2023 Oct; 102():222-228. PubMed ID: 37321378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
    Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y
    Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
    Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
    J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics analysis of amide proton transfer-weighted and structural MR images for treatment response assessment in malignant gliomas.
    Jiang S; Guo P; Heo HY; Zhang Y; Wu J; Jin Y; Laterra J; Eberhart CG; Lim M; Blakeley JO
    NMR Biomed; 2023 Jan; 36(1):e4824. PubMed ID: 36057449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
    Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
    Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients.
    Guo P; Unberath M; Heo HY; Eberhart CG; Lim M; Blakeley JO; Jiang S
    Neuroimage Clin; 2022; 35():103121. PubMed ID: 35905666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging.
    Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J
    World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully automated analysis combining [
    Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
    Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
    Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
    Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
    BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
    Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
    Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma: a preliminary study.
    Chen W; Liu G; Chen J; Wei Q; Ye Y; Du X; Feng J; Yan Z; Deng K; Liu X
    Eur Radiol; 2023 Jul; 33(7):5159-5171. PubMed ID: 36700956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
    Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining amide proton transfer-weighted and arterial spin labeling imaging to differentiate solitary brain metastases from glioblastomas.
    Chen L; Li T; Li Y; Zhang J; Li S; Zhu L; Qin J; Tang L; Zeng Z
    Magn Reson Imaging; 2023 Oct; 102():96-102. PubMed ID: 37172748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
    Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of true progression from treatment response in high-grade glioma treated with chemoradiation: a comparison study of 3D-APTW and 3D-PcASL imaging and DWI.
    Hou H; Diao Y; Yu J; Xu M; Wang L; Li Z; Song T; Liu Y; Yuan Z
    NMR Biomed; 2023 Jan; 36(1):e4821. PubMed ID: 36031734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
    Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
    J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
    Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
    Eur Radiol; 2024 Oct; 34(10):6820-6830. PubMed ID: 38491129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC
    PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
    Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
    Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.